Loading clinical trials...
Loading clinical trials...
Patients with chronic liver disease (CLD) are at risk of developing clinically significant portal hypertension (CSPH). In the Baveno VI consensus a new term "compensated advanced chronic liver disease...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Liver and Biliary Sciences, India
NCT07588854 · Chronic Liver Disease (CLD), Liver Fibrosis
NCT07280390 · Cirrhosis, Microplastics, and more
NCT07480057 · Chronic Liver Disease and ACLF
NCT07471542 · Cirrhosis, Chronic Liver Disease, and more
NCT06181409 · Advanced Chronic Liver Disease
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions